FindTrial
Sign In

The Uphold study Clinical evaluation of the Uphold Mesh for the surgical treatment of uterine-predominant prolapse: a prospective , multi-center trial

The Uphold study Clinical evaluation of the Uphold Mesh for the surgical treatment of uterine-predominant prolapse: a prospective , multi-center trial - Uphold Study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36892
Enrollment
20
Registered
2012-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolaps behandeling met toekomstig oog op vermindering van recidieven pelvic organ prolapse

Interventions

None listed

Sponsors

CHU de Nimes, France
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: stage II or greater uterine and anterior vaginal wall prolapse

Exclusion criteria

Exclusion criteria: under age 50

Design outcomes

Primary

MeasureTime frame
see above: composite outcome—

Secondary

MeasureTime frame
quality of life and bother scores and sexual function, measured with PFDI-20, PFIQ-7 and PISQ-12.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)